We’ve been advising on and closing cannabis transactions since 2013.
Our deep knowledge of biological supply chains, successful transactions and rapidly changing cannabis sector gives our clients confidence that we understand the full lifecycle and operational risks and opportunities they face. In the not too distant future, we believe the cannabis and life science sectors will continue to move towards each other and share more in common than they do now. We will continue to be on the forefront of providing valuable insights before, during and after this evolution.
David speaking at 2022 Global Investor Forum (GIF) during the International Cannabis Business Conference (ICBC)
The GEP Difference
Our team’s experience in business development and operations means that we can effectively and successfully lead incremental transactions such as joint ventures, co-development and cross-licensing, in addition to terminal transactions such as mergers, acquisitions and option-based arrangements. Learn more about our team here.
Established Pioneer
One of the first investment bankers in cannabis.
Operational Knowledge
In both life science and cannabis companies.
Bioprocessing Expertise
Inventor on two bioprocessing patents.
Transactional Fluency
Closed over 50 transactions from simple to complex structures.
Innovative Perspective
Inventor on three U.S. patents and Silicon Valley experience.
Synergized Solutions
We combine our unique backgrounds to provide valuable solutions.
Cannabis
We began working with cannabis companies in the early days of legalization, beginning in Colorado in 2013. We’ve worked with companies across the spectrum of cannabis, including THC+ and THC- (industrial hemp, molecular hemp) operators and ancillary companies. We started working with international cannabis companies in early 2016 and have worked on companies on six contents.
Life Sciences
Our experience in life sciences dates back to 1989, when biotech was booming in the U.S. We’ve worked at or with notable companies such as Synergen, Somatogen, Affymetrix and Atugen. We have worked across many sub-sectors, including:
